Stocks making the biggest moves midday: Kroger, Petco, Moderna, Roku and more CNBC These are the stocks posting the largest moves in midday trading. Kroger (KR) Moderna (MRNA) 5 days
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path? The Motley Fool 2 days
He Used to Bag Groceries. Now Kroger’s CEO Is Trying to Save a $20 Billion Deal. The Wall Street Journal 3 days
World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna Yahoo Finance 3 days
The Kroger Co. (KR): The Best Organic Food and Farming Stock to Add to Your Portfolio Insider Monkey 3 days
Is the Kroger-Albertsons merger really doomed? The deal’s chances, and what it means for consumers, explained Fast Company 4 days
Moderna’s Pain Continues Amid Flurry Of Downgrades Following ‘Tough’ R&D Day Investor's Business Daily 4 days
Kroger is accessible enough that the market can change its view quickly, says Jim Cramer YouTube 5 days
Moderna: Fresh Sell-Off On Cost Cutting Initiatives, Short-Term Outlook Troubling Seeking Alpha 5 days
Stocks making the biggest moves premarket: Moderna, Alaska Air, Oxford Industries and more CNBC 5 days
Blank: Kroger’s flat pricing reflects broader food trends, with food prices up 2.1% overall YouTube 6 days
Moderna Pulls Back on R&D and Delays Timeline for Profitability. The Stock Tumbles. Yahoo Finance 6 days
Moderna Crashes After Slashing Its R&D Budget, Issuing Light Guidance Investor's Business Daily 6 days
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid path CNBC 6 days
The drama is heating up over Kroger’s planned merger deal. What will its earnings say? MarketWatch 1 week
Kroger’s CEO says it isn’t the supermarket’s fault that groceries are more expensive, it’s due to things like credit card swipe fees and fuel costs Business Insider 2 weeks
Lightning Round: Moderna has to clean it up or the stock isn’t going to rally, says Jim Cramer YouTube 2 weeks
Moderna’s experimental mpox vaccine reduces severity of disease, early study finds MarketWatch 2 weeks